| Revenue growth | 3% YoY growth in FY26 despite Animal Nutrition business decline. |
|---|---|
| Margins | PAT margins improved to 16.8% in FY26 from 16.1% in FY25. |
| Demand visibility | Strong traction in Rice herbicides; Africa exports momentum remains high. |
| Management confidence | Cautiously optimistic for FY27; monitoring El-Nino and geopolitical developments. |
Growth
FY26 Revenue +3% YoY; EBITDA +6% YoY; PAT +7% YoY. Q4FY26 PAT grew 12% YoY to ₹111cr.
Outlook
Focus on demand generation, differentiated products, and channel partnerships for FY27. Leadership transition effective Sept 2026.
Risks
Prolonged rainfall, delayed rabi demand recovery, bio-stimulant regulatory challenges, and raw material inflation.
Earnings Call filed with NSE, NSE: SUMICHEM. Summary written with AI assistance from the document.
Sumitomo Chemical India Ltd: key numbers
- Share price
- ₹446.35
- Market cap
- ₹22,279 Cr
- Revenue (annual)
- ₹3,238 Cr
- Net profit (annual)
- ₹543.0 Cr
- P/E (TTM)
- 38.5×Sector 37.5×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 3.02%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sumitomo Chemical India Ltd
All →Sumitomo Chemical India Investor Presentation: Key Takeaways
Sumitomo Chemical reported resilient Q1FY27 results despite a difficult domestic operating environment. Revenue grew 1% to ₹1,063 cr, while Net Profit surged 20% to ₹215 cr, aided by an insurance claim.
Sumitomo Chemical India Earnings Call: Key Takeaways
Sumitomo Chemical delivered record profitability in a challenging FY26, reporting its highest-ever margins. Strategy focuses on specialty products, digital outreach, and upcoming leadership transition in September 2026.
Sumitomo Chemical India Q4 FY26 Results: Net Profit ₹111.3 Cr, Up 11.5% YoY
Sumitomo Chemical India Ltd reported revenue from operations of ₹683.7 Cr (+0.6% YoY) and net profit of ₹111.3 Cr (+11.5% YoY) for Q4 FY26.
- Key figure
- Net profit ₹111.3 Cr · +11.5% YoY